Vaccine against bird flu readied, just in case

May 1, 2014 by Steven Reinberg
WHO: drug-resistant bacteria now found worldwide

(HealthDay)—A vaccine to protect people against a potential outbreak of H7N9 bird flu has shown promising results, according to a new report.

This flu, first seen in humans in China last year, is common among birds and chickens, but so far isn't known to spread from person-to-person. However, people who have come into contact with infected birds have been sickened.

"An effective H7N9 vaccine is achievable," said researcher Dr. Niranjan Kanesa-thasan, from Novartis Vaccines in Cambridge, Mass.

If H7N9 flu were to become a pandemic, this preliminary work would make it simple to ramp up and do larger trials, he said.

This flu most commonly infects older people. As of late April, the World Health Organization said 139 cases of H7N9 flu were reported in China. More than 20 percent of those patients have died.

Robin Robinson, deputy assistant secretary for preparedness and response in the U.S. Department of Health and Human Services, said this vaccine is only one step his agency is taking to prepare for a pandemic flu outbreak.

"The vaccine described in this study is one of more than 150 medical countermeasures—drugs, vaccines, and diagnostics—the Biomedical Advanced Research and Development Authority has in the development pipeline in our quest to protect health during emergencies," he said.

This study—published online April 30 in Science Translational Medicine—"is an important step in moving this forward," Robinson added.

Because it's impossible to know when the next pandemic will occur or which virus will cause it, Robinson said preparedness is key.

"We are working with multiple manufacturers, including Novartis, to develop H7N9 , evaluate the candidates in clinical trials for safety and effectiveness, and stockpile H7N9 vaccine so our nation can respond quickly if this deadly virus emerges in the United States or becomes a pandemic," Robinson said.

In order to get an immune-system response, Kanesa-thasan said, the vaccine has to include a component called an adjuvant, in this case one called MF59.

This particular adjuvant is used in Europe to boost the effectiveness of , but has not been approved for use in the United States. "The pathway to approval of adjuvanted vaccine is long and arduous, as it requires significant evidence of safety and effectiveness," Kanesa-thasan said.

In addition, for the vaccine to be effective, two doses are needed—one to prime the body's immune system and another to cue the body to produce antibodies, he said.

To develop the vaccine, Kanesa-thasan and colleagues used what's called synthetic virus technology after the virus's genes were sequenced.

In a trial of about 400 people, the resulting vaccine was tested in human volunteers, who developed antibodies to the H7N9 virus. However, the researchers can't be sure the vaccine is effective because those vaccinated haven't been exposed to the actual virus.

Still, some of the antibody responses were very similar to the antibody responses seen in patients that survived the H7N9 flu, the study authors said.

Dr. Marc Siegel, an associate professor of medicine at NYU Langone Medical Center in New York City, thinks the odds of the H7N9 virus ever becoming a pandemic are slim.

"I don't think H7N9 is going to turn into a pandemic. There has been no history of a mutating to the point where it became a human ," he said.

But Siegel believes that creating a is a good idea, although he doesn't think it needs to be produced or stockpiled.

Explore further: Younger adults hit hardest this flu season

More information: "A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults," by S.A. Bart et al. Science Translational Medicine, 2014.

Related Stories

Younger adults hit hardest this flu season

April 15, 2014
(HealthDay)—The H1N1 flu was the predominant influenza strain in the United States this year, but it packed a lot less punch than in 2009 when it caused a worldwide pandemic, health officials report.

Pharma giant Novartis working on H7N9 vaccine

April 25, 2013
Swiss pharmaceuticals giant Novartis is researching a vaccine for the H7N9 strain of bird flu, its chief executive said Thursday, amid fears that the disease could mutate into a form that spreads among people.

Researchers studying vaccine to prevent potential bird flu pandemic

September 19, 2013
Scientists at the University of Maryland School of Medicine's Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian (bird) influenza (flu) ...

Bird flu expert working on vaccine that protects against multiple strains

May 10, 2013
(Medical Xpress)—As the bird flu outbreak in China worsens, a Purdue University expert is working on vaccines that offer broader protection against multiple strains of the virus.

China reports first H7N9 bird flu death this year

January 8, 2014
China has reported its first death from the H7N9 bird flu virus in 2014 after a significant drop-off in fatalities following an outbreak last year.

China reports new H7N9 bird flu death

January 17, 2014
China has reported a new death from the H7N9 bird flu virus, state media said Friday, bringing the toll this year to at least four as the disease returns following its 2013 outbreak.

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.